The expression of PTGDS, PTGDR and SLCO2A1 also shows a decreasing trend across normal lung, tumor lung, and metastatic brain tissues, as well as in early and advanced stages and at different differentiation levels. This evidence concerns the gene SLCO2A1 and neoplasm.